Hot Longevity Mandate: Europe-Based Venture Fund

21 Sep

The firm is a global investment platform specialized in the healthcare & nutrition sector. The firm is operating since 2010 as a multi-stage investment manager, dedicated to evidence-based investment in companies that are developing superior products and services within the healthcare, life science and nutrition market segments. The flexibility of its strategy will allow the firm to not only provide private funding for promising venture companies, but also operate on cross-over financings, IPOs, and offer significant equity financing to fast-growing and profitable companies within the space when they get more established. In 2020, the firm launched the a Europe Venture Fund supported by two family holdings, enjoying privileged access to sector expertise and industrial network within key segment of the Health & Nutrition market, globally. The allocation in venture capital ranges from €5M to €7M ($6M to $8M) per company. The firm invests in Europe, Israel, North America and Middle-East.

The firm is primarily focused on 4 target investments areas :

– Life Science Tools & Diagnostics: Synthetic Biology; Point of Care Solutions; High Value Diagnostics; Life science Tools; Software, system integration & data mngt; New Imaging Solutions.

– Contract Manufacturing & Pharma services: Regulatory & Compliance; Bio-Statistics & Data Analytics; Pharma / API Development & Supply; Contract Development & Manufacturing; Research/ Drug Screening Services; Clinical Trial Design & Monitoring.

– Therapeutic Intervention & Patient Management Services: Infectious Diseases; Orphan Diseases; Respiratory Disorders; Ophthalmology; Home care & Remote patient monitoring.

– Preventive Medicine and Nutrition: Medical food, Probiotics & Nutraceuticals; Food Tracking & Safety; Plant Science & Crop protection; Novel Ingredient & Alternative Proteins; Animal health & nutrition; Novel Farming & Food processing. The firm actively supports entrepreneurs and companies that bring differentiated solutions to unmet medical needs and improve access to high-value products and services.

The firm has 3 principles that guide their investments:

– Invest in people first. The firm is looking for exceptional teams with great integrity, passion and shared vision about what business model to build or expand.

– Back differentiated products and services capable of addressing poorly served clinical needs with the potential to generate substantial revenues in attractive segments of the healthcare market.

– Bring added-value to support great companies globally. The firm’s team must be convinced that its distinctive experience, sector insights and international relationships can materially help entrepreneurs succeed. The firm is performing both growth equity and venture capital investments, therefore the firm primarily interested in small / mid-size companies at different stages of development and could consider investments in public companies. The firm invests in both revenue-generating and pre-revenue companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email RESI@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: